Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma

被引:14
|
作者
Brundler, MA
Harrison, JA
de Saussure, B
de Perrot, M
Pepper, MS
机构
[1] Univ Geneva, Med Ctr, Dept Clin Pathol, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
[3] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England
[4] Unitas Hosp, NetCare Mol Med Inst, ZA-0140 Pretoria, South Africa
关键词
D O I
10.1136/jcp.2005.028118
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Oesophageal adenocarcinoma is an aggressive neoplasm with poor prognosis as a result of early lymph node metastasis. Aims: To measure lymphatic vessel density (LVD) in the neoplastic progression from Barrett's metaplasia to adenocarcinoma and determine whether LVD can predict the risk of cancer. In addition, to correlate LVD with lymph node metastasis and assess whether LVD could be used as a prognostic indicator for outcome or survival. Methods: LVD and microvascular density (MVD) were assessed after immunohistochemical staining of vessels in Barrett's metaplasia, dysplasia, and adenocarcinoma tissues and were correlated with clinicopathological features. Results: LVD was significantly reduced in adenocarcinoma, being half that seen in normal stomach/oesophagus or metaplasia/dysplasia. LVD did not correlate with tumour grade, stage, or clinical outcome; however, patients who had either lymph node metastasis or invasion of tumour cells into peritumorous lymphatic vessels had a significantly worse overall survival. MVD was also assessed as a prognostic marker; its increase appeared to be linked more with the development of Barrett's metaplasia than adenocarcinoma. Conclusions: The reduction in lymphatic vessel numbers was not useful for determining disease outcome in the patient group studied. It is the entry of tumour cells into pre-existing peritumorous lymphatic vessels that confers a significantly worse overall survival.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [21] Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression
    Kastelein, F.
    van Olphen, S. H.
    Steyerberg, E. W.
    Spaander, M. C. W.
    Bruno, M. J.
    GUT, 2016, 65 (04) : 548 - 554
  • [22] SYMPTOMS AND ENDOSCOPIC FEATURES AT BARRETT'S OESOPHAGUS DIAGNOSIS: IMPLICATIONS FOR NEOPLASTIC PROGRESSION RISK
    Coleman, H. G.
    Bhat, S.
    Murray, L. J.
    McManus, D.
    Gavin, A. T.
    Johnston, B. T.
    GUT, 2013, 62 : A6 - A6
  • [23] Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation
    Immanuel, A
    Lamb, PJ
    Wayman, J
    Preston, S
    Griffin, SM
    BRITISH JOURNAL OF SURGERY, 2002, 89 (05) : 626 - 626
  • [24] Association between occupation type and progression of Barrett's oesophagus to oesophageal adenocarcinoma
    Bhattacharjee, Santanu
    Caygill, Christine P. J.
    Watson, Anthony
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (01) : 115 - 116
  • [25] M2-PK expression in the progression of Barrett's oesophagus to adenocarcinoma
    Koss, K
    Harrison, RF
    Jankowski, J
    GUT, 2003, 52 : A47 - A48
  • [26] ASSOCIATION BETWEEN OCCUPATION TYPE AND PROGRESSION OF BARRETT'S OESOPHAGUS TO OESOPHAGEAL ADENOCARCINOMA
    Bhattacharjee, Santanu
    Caygill, Christine
    Watson, Anthony
    GUT, 2019, 68 : A135 - A135
  • [27] Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus
    Cook, Michael B.
    Drahos, Jennifer
    Wood, Shannon
    Enewold, Lindsey
    Parsons, Ruth
    Freedman, Neal D.
    Taylor, Philip R.
    Ricker, Winnie
    Abnet, Christian C.
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1383 - 1390
  • [28] Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett’s oesophagus
    Michael B Cook
    Jennifer Drahos
    Shannon Wood
    Lindsey Enewold
    Ruth Parsons
    Neal D Freedman
    Philip R Taylor
    Winnie Ricker
    Christian C Abnet
    British Journal of Cancer, 2016, 115 : 1383 - 1390
  • [29] NSAIDs, Barrett's oesophagus and adenocarcinoma prevention
    Vainio, H
    Morgan, G
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1997, 6 (02) : 200 - 200
  • [30] MOLECULAR ABNORMALITIES IN PAEDIATRIC BARRETT'S OESOPHAGUS: CAN WE TEST FOR POTENTIAL OF NEOPLASTIC PROGRESSION?
    Cohen, M.
    Thomson, M. A.
    Dyson, M. J.
    Wheeler, M. R.
    Dhandapandi, A.
    Sethuraman, C.
    Maltby, E. L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E43 - E44